Pikagi
Charu Aggarwal, MD, MPH, FASCO Profile Banner
Charu Aggarwal, MD, MPH, FASCO Profile
Charu Aggarwal, MD, MPH, FASCO

@CharuAggarwalMD

11,627
Followers
2,204
Following
1,284
Media
7,538
Statuses

Leslye M. Heisler Professor of Lung Cancer Excellence @PennMedicine | AD @PC31 | #CCC Chair @ASCO | Tweets my own | COI:

Philadelphia, PA
https://t.co/wRjWHrWfxB
Joined June 2018
Don't wanna be here? Send us removal request.
Pinned Tweet
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
8 months
Effective July 1, you can call me PROFESSOR Aggarwal!🌟🌟🌟 Thrilled to have been promoted @Penn . I could not have done it without the incredible mentorship and collegiality of my colleagues @PennMedicine @PennCancer (and worldwide). Special thanks to all the letter-writers and
Tweet media one
137
11
615
Last Seen Profiles
William Coleman

@willcoleman1988

Vancouver Film School

@vfs

Audria Marke

@AudriaMark15561

cuki cewe papua asli

@cukienaknikmati

First Principles

@1stPrinciplesFM

こーたろ

@koutaro1023

ناصر الدوسري

@ttxuorr

郭家榮

@guojiarong2

Chica _transhot

@Daniela93259974

Masmoor

@M_asMoor

Waquar Hasan

@WaqarHasan1231

Suka STW Gendut

@StwGendut

Socio

@revueSocio

INFO BOKEP LOKAL TANTE SEMOK

@bokeplokalmalam

The Sighting Lap

@thesightinglap

Nicolas Ibarguen

@nibarguen

soso!

@lfwife

ᗪᑌᗩᒪIᑭOᐯII ᗰYOᗪ🍯

@lipahoneyboy

Deane Dragons U16s

@TDCCdragons

Pasindu Senanayaka

@PasinduSenanay7

WEB3_Inu

@web3_inu

nilsu

@nilsumag

كاريزما..🎻

@t_2se

🔥♠️🫦mona monmon🫦♠️🔥

@mona_monmon69

Raja Binor Stw

@BinorRaja

Even More Safer

@MaecyBae

Aidan Kinner

@kinner_aidan

Adela Horakova

@Adela_Horak

ناصر الدوسري

@ttxuorr

Councillor kemigisha Sharon

@SautiSharon

R

@justra2_

つき

@tsuk_i1

147 Neuquén Capital

@147Neuquen

INFO BOKEP LOKAL TANTE SEMOK

@bokeplokalmalam

First Principles

@1stPrinciplesFM

Sima Bart

@sima_bart

@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 years
My husband like me, is an oncologist. Like our colleagues, we are anxious & grieving. But we’re learning new ways to de-stress. With one foot in front of another, we will show up, and take care of our pts when they need us most. A little levity in the time of #COVID19 @ASCO
38
130
1K
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
1 year
Humbled and honored to be appointed Section Chief for Lung/HN cancer @PennMedicine @PennCancer ! Grateful for all the mentorship and support, and excited for what the future has in store with exceptional colleagues @CoreyLangerMD @MMarmarelis @LovaSunMD @AditiSinghMD @CCiunci
Tweet media one
104
17
478
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
4 years
Three people pose for a photo during the Spanish Flu in 1918. Almost a century later, so many things are the same, yet so different... #History #Lessons #MaskUp #COVID19
Tweet media one
12
169
419
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
3 years
I don’t get to update my profile often, so this is FUN!! Thrilled to be joining the @PennPrecisMed team as Associate Director to advance the footprint of #PrecisionMedicine across @PennMedicine @PennCancer @PennMDForum @david_b_roth2 @kevinbmahoney @jonepstein1
Tweet media one
56
14
401
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 years
Promoted to Associate Professor @PennMedicine @PennCancer ! So amazing to hear+see the news in my office with a congratulatory message from @lynn_schuchter and colleagues in the division of hem onc! Grateful for my mentors, advisors, family and letter writers. #Yay !!!!
Tweet media one
Tweet media two
69
16
394
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
4 years
Happy July 1! #NewAcademicYear #Promotion
59
7
337
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 years
Hi, I’m a medical oncologist. You might know me from my greatest hits “Sugar doesn’t feed cancer” “Vitamin C doesn’t cure cancer” And the chart topping “Palliative therapy doesn’t mean giving up...”
@heyjulesfern
Jules Glegg 🏳️‍⚧️ @[email protected]
@heyjulesfern
5 years
Hi, I’m a senior engineer. You might know me from my greatest hits “but *why* is it null?” “There is greater honor in deleting code than in writing more” And the chart-topping “let’s just walk over to them and ask”
197
2K
12K
5
43
297
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 months
So honored to receive the “Woman Disruptor of the Year Award” today- thank you @HemOncToday for the wonderful recognition! @PennCancer @PennMedicine @PennMDForum @ShikhaJainMD @marklewismd @WimedicineOrg
Tweet media one
@HemOncToday
HemOnc Today
@HemOncToday
5 months
Breaking barriers & shattering ceilings is what the Woman Disruptor of the Year is doing 💁‍♀️ The award, presented with @WimedicineOrg , goes to @CharuAggarwalMD ! 🏆 Dr. Aggarwal is leading & setting the tone for successful careers with meaningful advancements. Congrats! 🎉
Tweet media one
4
9
25
35
22
245
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
4 years
New guidelines for vaccinating individuals with #Cancer with #COVID19 vaccines released by @NCCN ✴️Vaccine is recommended for all pts on active therapy ✴️Delay vaccine ~3 months following transplant/ CAR-T therapy ✴️Immunize household members
Tweet media one
8
144
235
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 years
Tonight I was appointed the inaugural chair holder of the Leslye Heisler endowed professorship @Penn @PennCancer to support research in #LungCancer . I am incredibly honored, humbled & grateful to the Heisler Family for this gift, and for everyone who has supported me. #CureCancer
Tweet media one
Tweet media two
32
13
221
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
4 years
Few words of wisdom from Dr. Fauci regarding cancer care and #cancer screening during the #COVID19 pandemic ⁦ @PennMedicine ⁩ ⁦ @PennCancer ⁩
8
34
208
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
2 years
Ready to #ConquerCancer - headed to Chicago! #ASCO22 ⁦ @ConquerCancerFd ⁩ ⁦ @ASCO ⁩ ⁦ @PennMedicine ⁩ ⁦ @PC3Innovation ⁩ ⁦ @PennPrecisMed ⁩
Tweet media one
5
6
206
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
2 years
Pembrolizumab is now approved by the @US_FDA for adjuvant therapy. Note that there is no restriction by stage or PDL1 expression, unlike the approval for atezolizumab. I don’t think this rather broad approval including in PDL negative population is helpful #LCSM
Tweet media one
10
52
199
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
2 years
Prioritizing speaking opportunities as a parent of young kids is super hard, especially in academic medicine. But, these are the moments that are worth it! We have a Swim Champion in the family! 🙌🏽 Won’t miss this for the world! #ProudMom #WorkLifeBalance @WeAreWLO @WomeninOnc
Tweet media one
18
5
194
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
3 years
5-year outcomes with first line pembrolizumab c/w chemo in patients with #NSCLC PDL1>50% published in @ASCO_pubs #JCO ✴️Median OS doubled (26.3 vs 13.4)! ✴️5 year OS rate 31.9% vs 16.3%!! ✴️Benefit seen despite 66% crossover!!! @MartinReck2 @JulieBrahmer @LealTiciana #LCSM
Tweet media one
Tweet media two
7
70
184
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
2 years
Thrilled to be leading efforts across @PennMedicine to advance the footprint of #PrecisionMedicine and lead efforts in Precision Oncology Innovation @PC3Innovation @PennPrecisMed @PennCancer . Humbled, and stoked for what the future has in store! @HemOncWomenDocs
@PC3Innovation
Penn Cancer Innovation
@PC3Innovation
2 years
We congratulate PC3I Faculty @CharuAggarwalMD on her appointment as Director of PC3I’s Program in Precision Oncology Innovation. 🔍Learn more about Dr. Aggarwal: ➕Follow us to hear more about our work in #precisiononcology #innovation .
Tweet media one
17
2
70
26
15
183
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
1 year
Are you even going to #ASCO23 if you don’t have a #PlaneSelfie ? ✈️ Ready to #ConquerCancer @ASCO ! See you all in Chicago! @ASCOPres
Tweet media one
13
2
168
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 years
My husband and I continue our #COVID19 journey with some de-stressing moves. As we close out the Easter weekend, sharing some levity before we all return to work tomorrow. #COVID19 #Oncologists @ASCO @drdonsdizon
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 years
My husband like me, is an oncologist. Like our colleagues, we are anxious & grieving. But we’re learning new ways to de-stress. With one foot in front of another, we will show up, and take care of our pts when they need us most. A little levity in the time of #COVID19 @ASCO
38
130
1K
9
15
170
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 months
So honored to have received #FASCO today, and be able to share it with so many dear colleagues and friends. It’s an honor to serve @ASCO in its mission! @PennCancer @PennMedicine @PennMDForum @OncoAlert
Tweet media one
14
22
165
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
2 years
#ASCO22 was amazing, but nothing, nothing beats time at the pool with my kids! Happy Saturday Morning! Hello weekend! @ASCO @HemOncWomenDocs
Tweet media one
5
2
154
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 months
Beautiful, eloquent and poised discussion of #LAURA by @LeciaSequist emphasizing the importance of PFS benefit in this population, preventing morbidity from CNS Mets while balancing the issue of cost, QoL and biomarkers 👏🏽🫁 @ASCO #ASCO24 @OncoAlert
Tweet media one
Tweet media two
Tweet media three
Tweet media four
7
45
150
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
1 year
We know that #ComprehensiveMolecularGenotyping is essential in patients with advanced #NSCLC - but do we know if availability of results impacts #Survival ? In a real world cohort study, we asked this question @MMarmarelis - out now in @JCOPO_ASCO @ASCO 👉🏽
Tweet media one
6
65
142
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
4 years
It's publication Friday! Excited to share the results of @PennCancer study on role of serial monitoring of #ctDNA #NGS as a biomarker of response in pts receiving pembrolizumab based therapy for 1L met #NSCLC published in @ASCO_pubs #JCOPO #LCSM
Tweet media one
3
40
138
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
2 years
There are many gaps associated with #Biomarker Testing in #NSCLC . Striking to see that using commercial and medicare claims data, approximately 64% of potentially eligible pts do not get personalized therapy! @JCOPO_ASCO
Tweet media one
3
66
137
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
4 years
SO excited to co-chair @PennCancer ’s #COVID19 and Cancer Conference, with Dr. Fauci as our guest speaker!! I am honored and humbled to lead a Q&A session with Dr. Fauci with Dr. Vonderheide, in what promises to be an amazing evening. Woohoo!
Tweet media one
Tweet media two
Tweet media three
3
25
131
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 months
Congratulations to @jillfeldman4 for being awarded the patient advocate award this year @ASCO #ASCO24 - we are so lucky to have your wisdom, candor and friendship! @EGFRResisters #LCSM @OncoAlert
Tweet media one
3
29
132
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
4 years
ctDNA clearance is becoming an emerging molecular biomarker of response. Data from #TATTON trial presented @AACR #AACR20 show that clearance of circulating #EGFR ctDNA from plasma can predict for longer PFS, longer PFS seen in patients that cleared ctDNA (9.1 mo vs. 3.9 mo) #LCSM
Tweet media one
2
54
128
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
3 years
A group of my closest pelo-oncers convinced me to get this shirt. Can’t say I don’t love it! 🚴 🏃🏾‍♀️ 💜 #WomenInOnc @onepeloton
Tweet media one
16
1
130
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
2 years
Roses are red, violets are blue, I submitted my @ASCO abstracts, have you... #ASCO23 #ValentinesDay #Oncology
Tweet media one
10
8
126
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 years
Overheard this conversation b/w my girls this morning: 3 yo: I want to be a doctor when I grow up, just like mama. 5 yo: I don’t know, I want to be a mama when I grow up, just like mama. I like both options! I guess I’m doing something right! #parenting #WomenInmedicine
4
3
120
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
1 year
En route to @myESMO #ESMO23 ! Looking forward to an exciting meeting with an impactful scientific agenda with practice changing implications in #LungCancer . Can’t wait to connect with friends! Madrid, see you in 7 short hours! 🇪🇸
Tweet media one
9
4
120
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
4 years
Thankful and incredibly grateful to have received the #CovidVaccine today @PennMedicine #COVID19 #Igottheshot
Tweet media one
Tweet media two
2
6
119
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
3 years
Nothing more brutal than a manuscript rejected after *third* round of extensive revisions. Nothing. 😒 Happy Monday #MedTwitter
13
3
119
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
2 years
The action is about to begin! ⁦ @ASCO ⁩ #ASCO22 Annual Meeting - kicking off the meeting with NSCLC Met oral session! Join us #LCSM
Tweet media one
4
5
117
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 years
Our paper exploring the value of plasma tumor mutation burden ( #TMB ) as a biomarker in #NSCLC pts receiving #pembrolizumab based therapy, including chemo-immunotherapy came out online @CCR_AACR today. Why this may be important? (1/6) @EricaCarpenter1
5
46
111
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
3 years
5 year update of PACIFIC data being presented @ASCO #ASCO21 . Using consolidation #Immunotherapy , with one year of duevalumab, substantial % of pts are alive at 5 years 42.9% vs. 33.4% #LCSM
Tweet media one
Tweet media two
2
40
108
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
2 years
My amazing AA made a folder for #ASCO22 including an annotated map of the conference hall and the exhibit booths! 😮 So grateful to have a rockstar supportive team who understands the craziness of @ASCO AM w/o even being there! @PC3Innovation @PennPrecisMed @HemOncWomenDocs
Tweet media one
Tweet media two
16
5
109
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
4 years
Today, I kneeled in silence with other members of @PennMedicine @PennCancer @Penn in support of #BlackLivesMatter #WhiteCoatsForBlackLives
1
10
107
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 months
The curve again! 👑 #ASCO24 @ASCO
Tweet media one
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 months
Let’s take a minute. Have we seen anything like this in NSCLC before? mPFS NR at 5 years? 👏🏽👏🏽👏🏽👏🏽 These curves are very impressive, and should urge us to think about management of AEs and optimize 1L Tx for ALK+ NSCLC @ASCO #ASCO24 @ALKPositiveinc @OncoAlert @bensolomon1
2
31
96
4
24
110
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
7 months
#ASCO24 News Planning with @ASCO Cancer Communications Committee today! Thanks to this group of volunteers for the incredible effort to create a fantastic press program for the AM. Lucky to have had @elmayermd , immediate past chair guide me in this role of CCC Chair and look
Tweet media one
7
7
106
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
2 years
#TumorBoardTuesday Why is it important to #test ? - Survival has increased tremendously! - We have a real chance to offer personalized therapy to our patients! - lower toxicity! #LCSM #LungCancer #BiomarkerTesting
Tweet media one
1
34
105
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 years
. @HosseinBorghaei was celebrated today amongst friends and family @FoxChaseCancer as he became the inaugural Gloria and Edmund Dunn chair in Thoracic Oncology. I was honored to be invited to celebrate and humbled to call him my friend. Congratulations Hoss!
Tweet media one
Tweet media two
18
7
105
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
4 years
Sotorasib in KRASMT #NSCLC @myESMO #ESMO20 - 59 pts with NSCLC, 34 treated at 960 mg - G3/4 in ~18%, diarrhea in about 25% - ORR 32.2.%, median DOR 10.9 mos - Activity in STK11MT as well, and across different mutations - Promising drug, excellent presentation #LCSM
Tweet media one
Tweet media two
Tweet media three
Tweet media four
3
41
102
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
4 years
KRAS inhibitors are finally here! ➡ Not one, but 4 other drugs are in clinical trials, w/ others being developed. ➡ There is an impact of co-MT, including STK11/KEAP ➡ Future lies in combination therapies, in trials now #WCLC20 @IASLC @kRasKickers
Tweet media one
Tweet media two
Tweet media three
0
32
103
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
4 years
This! #Election2020 Historic results. First woman Vice President, first woman of color, first president elect with >70mil votes! #TimeToHeal #Timetocelebrate
Tweet media one
3
6
103
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
3 years
Final OS analysis of J-ALEX Alectinib vs Crizotinib ✴️ No significant OS difference BUT ✴️ Majority of patients crossed over to alectinib (~78%) @ALKLungCancer @alk_fusion @ASCO #ASCO21 @OncoAlert
Tweet media one
Tweet media two
Tweet media three
4
33
100
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
3 years
I am reviewing #ASCO21 @ASCO top abstracts across categories in #NSCLC Next up, #Immunotherapy #LCSM Links here 👇 9000 - 9001 - 9016 - 8511 - 8512 -
Tweet media one
3
32
100
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
3 years
Plasma based genotyping can increase detection of molecular alterations in patients with #NSCLC - and we are building upon this observation () Working w/ Drs. Jeff Thompson and @EricaCarpenter1 , we are continuing to move the front door... (1/6)
8
22
97
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
1 year
#ASCO23 @ASCO #LCSM CSS Combination chemotherapy with #gefintib #osimertinib ✨ started with G—>changed to O ✨ N=501, ex19 del or L858R ✨ mPFS 18mo, p=0.005 ✨ O arm mPFS 25.2 mo ✨ OS NOT better!! @EGFRResisters @OncoAlert @LungCancerRx
Tweet media one
Tweet media two
Tweet media three
Tweet media four
3
42
96
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 months
Let’s take a minute. Have we seen anything like this in NSCLC before? mPFS NR at 5 years? 👏🏽👏🏽👏🏽👏🏽 These curves are very impressive, and should urge us to think about management of AEs and optimize 1L Tx for ALK+ NSCLC @ASCO #ASCO24 @ALKPositiveinc @OncoAlert @bensolomon1
@n8pennell
Nathan A. Pennell MD, PhD, FASCO
@n8pennell
5 months
Not to steal the thunder from the oral session today, but this is the CROWN PFS curve, more or less flat between 2-5 years and still 60% progression free at 5 years! #ASCO24 #LCSM Is it worth the side effects of lorlatinib to turn ALK+ NSCLC into CML?
Tweet media one
8
30
104
2
31
96
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
2 years
Thrilled to see "Aumolertinib in EGFR-Mutant Lung Cancer: Will the Promise of Cost Disruption Ease Access?" in print. We discuss implications for clinical trial design, and cost, and access - with the brilliant @oncology_bg out in @JCO_ASCM #LCSM
Tweet media one
9
32
94
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
3 years
Sexual Harassment in Oncology. For anyone who thinks this doesn't happen in medicine, I urge you to look at this study from @IshwariaMD @DrMarkham @DrSGraff @JuliaLClose @luvpooh101 @reshmajagsi et al, detailing the incidence (70%!!!!) and outcomes #ASCO21 @HemOncWomenDocs
Tweet media one
Tweet media two
Tweet media three
1
35
96
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
1 year
Voting for the @ASCO Election is now open. I am honored and humbled to be running as one of the candidates for the Nominating Committee, alongside many talented friends and colleagues. Visit to learn more about the candidates and place your votes!
4
16
93
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
1 year
#ASCO23 @ASCO KN671 - 1st IA: Periop ChemoIO + Adj IO Dual endpts EFS/OS N=797–>397 in P ✨~40% completed adj tx ✨1/3rd split across PDL1 levels ✨EFS HR=0.58, mEFS NR w P ✨OS HR=0.73 @OncoAlert @ASCOPost
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
34
90
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
2 years
Molecular Testing in Early Stage NSCLC @JAMAOnc @JackWestMD and I discuss that it is most appropriate to get comprehensive NGS in early stage NSCLC where systemic therapy is indicated. #LCSM #BiomarkerTesting
Tweet card media
Molecular Marker Testing in Curable Non–Small Cell Lung Cancer

This Viewpoint describes the use of broad molecular marker testing in patients with early-stage non–small cell lung cancer

jamanetwork.com
2
41
87
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
2 months
Humbled to have been part of the @ASCO Nominating Committee process with @ASCO leaders as we gear up for the annual ASCO Election! Another successful day at #ASCOHQ @ASCOPres @lynn_schuchter @DrEricWiner @cardismith @rachnatshroff @montypal @KimmieNgMD @NehaVapiwala Drs. Eric
Tweet media one
2
10
91
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 years
Probably the best infographic GIF I have seen on the #COVID19 epidemic. We must all do our part #HandWashing #Containment #FlattenTheCurve
2
61
89
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 years
Meta-analysis of AEs post #Immunotherapy w aPD-1/PDL-1 ~ 20k pts, 66% w/ at least 1 AE, 14% >= G3 AE. Sobering reminder that even though overall irAE #pneumonitis was 2.7%, and >= G3 was only 0.67%, it was the cause of death for 28% of the cases! #OncoAlert #LCSM @JAMAOnc
@JAMAOnc
JAMA Oncology
@JAMAOnc
5 years
Comprehensive meta-analysis of 125 trials treating w anti-PD-1 & anti-PD-L1 inhibitors across a broad range of cancers reveals patterns of observed toxicities & significant differences among different checkpoint inhibitors #immunotherapy
4
112
150
2
39
88
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
3 years
“I can’t be your mentor without occasionally being your tormentor” - another gem from @TedLasso Happy Weekend, everyone! #Believe @MedLasso @TheRealDoctorT @ETSshow
2
6
88
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 months
We are so proud to be part of “House of Lynn” @ASCOPres @ASCO #ASCO24 Grateful to have fantastic leadership in the house @AngieDemichele @PennCancer @PennMedicine @PennMDForum @OncoAlert @PC3Innovation
Tweet media one
Tweet media two
1
20
88
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 years
I’m a doctor. I’m worried. For my patients. For my family. For my friends. For nurses. For dozens of health care workers. For myself. @Philadelphia : Do your part #SocialDistancing #StayatHome @PennMedicine #COVID19 #LCSM
@PennMedicine
Penn Medicine
@PennMedicine
5 years
"My advice is that universally people should assume that they could be carrying the virus." Dean J. Larry Jameson, MD, PhD, spoke with @phillymag on why #socialdistancing is so important. Stay home to keep yourself and others safe.
1
28
57
3
26
87
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 years
Getting ready for @IASLC #WCLC19 ! Which data are you most excited to see? I’ll start (in no particular order): - tTMB in KN21, KN189 - Neg predictor MT in plasma for response to IO (MYSTIC) - plasma TMB in chemoIO - CASPIAN: durva+EP in SCLC - FLAURA 3 #OncoAlert #LCSM
Tweet media one
4
25
87
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
3 years
In my opinion, we need OS benefit before we can adopt a year of adjuvant immunotherapy as the new SOC #LCSM #ASCO21 @ASCO
7
9
86
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
4 years
Hang in there everyone!! #InThisTogether #StayHome #WashYourHands #COVID19 @theweeknd inspiration for the #Weekend
2
7
87
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 years
Those who cannot learn from history are doomed to repeat it. Yet those who *do* study history are doomed to standby helplessly while everyone else repeats it. We must learn from 1918, and from Italy #InItTogether #SocialDistancing #COVID19
Tweet media one
1
39
84
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 months
Lung Plenary #LAURA Osi in Stage III unresectable #NSCLC - amazing results and will definitely affirm my practice to deliver targeted tx for pts w/ EGFR Mutation @EGFRResisters mPFS 39.1 vs. 5.6 months, HR 0.16 Well done, @RamalingamMD and investigators @ASCO #ASCO24
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
27
85
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
2 years
Wonderful to catch up with friends and gearing up for a great #ASCO23 with fantastic leadership @ASCOPres @lynn_schuchter @AngieDemichele @tomleblancMD @SoniSmithMD @ASCO
Tweet media one
Tweet media two
Tweet media three
5
9
85
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
4 years
FDA Approves New Pembrolizumab Dosing Schedule, this is really impactful in the #COVID19 era, and will help us minimize exposure for patients with #NSCLC #LCSM @OncoAlert
2
30
83
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
4 years
It’s only been half a clinic day, but so far ALL my patients for this morning have been fully vaccinated. 💪🏽👏🏽 #COVDID19 #Hope #VaccinesWork
0
1
82
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
1 year
Thrilled that our RCT #TESTING is enrolling! Funded by @theNCI , this trial will answer an important question about the introduction of "early liquid bx" in NSCLC and patient education via Telehealth #BiomarkerTesting #LCSM #NCT05790460 @kate_rendle
Tweet media one
6
17
83
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 years
New report of Exon 16–Skipping HER2 as a mechanism of resistance in #EGFR L858R/T790M+ #NSCLC post-osimertinib; very important to remember to obtain molecular sequencing at the time of PD @JTOonline #LCSM
5
34
79
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
4 years
Ending #WCLC20 by chasing my 6 y old down the slopes. Guess couldn’t have done this in Singapore! 🙌🏼⁦ @GlopesMd ⁩ @IASLC !
Tweet media one
3
0
80
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
7 months
Leaving @myesmo @IASLC #Prague with a full heart- so amazing to see old friends & new and hear advances in #LungCancer ! #ELCC24 @danieltanmd @AnneTsao2 @JhanelleGray @ReckampK @JoeChangMD @PC3Innovation @PennCancer
Tweet media one
0
6
82
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
4 years
#Biomarker Testing for #NSCLC ➡️ Only a third to half of pts getting tested for EGFR/ALK/BRAF/ROS ➡️ Only 50% tested within 30 days of new dx ➡️ Median test to treatment ~ 16 days While there seems to be a trend towards improvement, we NEED to do better! #LCSM @IASLC #WCLC20
Tweet media one
Tweet media two
Tweet media three
Tweet media four
3
32
81
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
2 years
We will be starting the meeting with Metastatic NSCLC - Lung Oral Abstracts at 1p CST! @ASCO #LCSM #ASCO22
4
6
80
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
6 years
Honored and humbled to be accepted into the @ASCO Leadership Development Program ‘19-‘20. Looking forward to a year of learning from the best, and to connect with friends, mentors and colleagues who have been previous #asco_ldp participants! @PennCancer
@ShaalanBeg
Shaalan Beg MD MBA FASCO
@ShaalanBeg
6 years
Congrats @VamsiVelcheti @DrSGraff @PGrivasMDPhD et al on joining the @ASCO Leadership Development Program. Its a great learning experience! ((Use #asco_ldp to connect w prior (and future) participants! ))
1
3
30
11
2
81
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 months
#ADRIATIC - new standard of care in #SCLC , where we have not seen an advance in >2 decades. Truly historic data with use of immunotherapy consolidation #LungPlenary @DavidRSpigel @LaurenByersMD @ASCO #ASCO24 @OncoAlert
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
23
81
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
1 year
Before we all continue to pile on #ADAURA , can someone tell me % of patients who received Immunotherapy upon progression on IM-010 or KN-91. See figure. I will remind you that immunotherapy alone or in combination is THE SOC for 1L Metastatic NSCLC. How come we don't see that
Tweet media one
@DrewMoghanaki
Drew Moghanaki 🐕
@DrewMoghanaki
1 year
Hey @JackWestMD , did you already see p25 of the #ADAURA supplementary appendix? Curious of your thoughts given 88% of pts in the placebo arm who developed progression and were fit enough to get more tx got a TKI. #ASCO23
Tweet media one
5
5
23
9
14
79
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
3 years
Going Live for #TTLC22 in less than 5! Tune in to our Immunotherapy Session live now! @IASLC #LCSM ⁦ @LeciaSequist ⁩ ⁦ @DrRoyHerbstYale ⁩ ⁦ @RamalingamMD ⁩ ⁦ @HwakeleeMD ⁩
Tweet media one
2
4
80
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
3 years
Bad scans are hard for oncologists too
1
7
80
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 years
So proud of @PennMedicine Internal Medicine Housestaff. They are compassionate, caring, deliberate and kind in the face of uncertainty. Presenting to you #Ninjas of inpatient oncology @PennCancer . Humbled to work with each one of them @PennMDForum #InThisTogether #COVID19
Tweet media one
3
6
77
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 years
As many of us leave the #ASC019 meeting, let’s take an opportunity to thank the @ASCO staff, volunteers, and meeting organizers for a job well done. Getting so many people under one roof and keep the “buses running on time” is no child’s play. Congratulations to these #Heroes
Tweet media one
1
20
79
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
3 years
Thrilled to serve as a Meeting Co-Chair alongside @LeciaSequist @RamalingamMD @DrRoyHerbstYale and Dr. Bunn. Looking forward to reinvigorating the #SantaMonica Meeting #TTLC22 back to in person (🤞🏽) @IASLC #LCSM @KristinRicheim1 Save the date(s) 👇🏽
@IASLC
IASLC
@IASLC
3 years
@IASLC #TTLC22 Meeting Chairs invite you to Save the Date for this dynamic meeting (Feb 23-26). Presenters will summarize data on relevant targets for new therapies & preclinical/early clinical data for ea. of the drugs directed against these targets #LCSM
Tweet media one
0
3
15
2
3
79
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 months
Wonderful tribute to Dr. Jamie Von Roenn who has been a force in shaping educational programming for @ASCO , who is retiring this year - the Jamie Avon Roenn Excellence in Teaching Award announced tonight at @ASCOPres dinner 👏🏽👏🏽👏🏽 Standing Ovation! She has been an exceptional
Tweet media one
Tweet media two
Tweet media three
1
24
79
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
1 year
So much GREAT science being presented @ASCO #ASCO23 Check out @OncoAlert @imedverse @ASCOPost @HemOncToday for updates! #LCSM
Tweet media one
3
9
78
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
4 years
I am hopeful for a better future for my fellow Americans, my patients and my family. I voted today to make my voice heard. Have you? #MakeAmericaKindAgain #VOTE
Tweet media one
Tweet media two
0
3
78
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
5 years
#OncoAlert phase III KN48 data just presented at #ASCO19 Pembro Improves OS against EXTREME with or w/o chemo, in pts w/ PD-L1 CPS>1. RR higher when added w/ chemo, but so is toxicity. Emerging clear standard to go with P, PC—> I have reservations given high tox #HNCSM
Tweet media one
Tweet media two
Tweet media three
Tweet media four
3
37
75
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
3 years
I was shocked to read the @TheCancerLetter piece today. Heard from many colleagues that this behavior was known in the field and went on for years. Years. Check out this abstract on findings of sexual harassment of oncologists @ASCO #ASCO21 . We need to do better.
Tweet media one
@IshwariaMD
Ishwaria Subbiah, MD MS FASCO
@IshwariaMD
3 years
. @theNASEM “Iceberg” provides the critical framework around which we reconcile our perceptions and understanding of #sexualharassment . The egregious cases make the news but we’re here to address that COMPLICIT OCEAN that keeps this ENTIRE ICEBERG afloat.
Tweet media one
2
37
106
2
25
77
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
2 years
⁦ @NarjustDumaMD ⁩ ⁦ @GoHealio ⁩ Health Equity Award! 🤗
Tweet media one
4
6
76
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
2 years
Fantastic women in oncology session ⁦ @IASLC ⁩ #WCLC22 Missed a pic w/ ⁦ @karenkellymd ⁩ So good to connect with women leaders! ⁦ @HwakeleeMD ⁩ ⁦ @NarjustFlorezMD ⁩ ⁦ @clarissamathias ⁩ ⁦ @ElaineShumMD ⁩ ⁦ @RachelSanbornMD ⁩ ⁦ @NaglaAKarimMD
Tweet media one
0
11
74
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
4 years
T4. In the future, we will be using liquid biopsy across the spectrum of #LungCancer management including screening #LCSM
Tweet media one
4
23
74
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
2 years
Celebrating the success of #TTLC23 in a different way! Cheers! @IASLC @LeciaSequist @JoelNealMD #LCSM
Tweet media one
5
0
75
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
8 months
Good morning, Santa Monica! ☀️ #TTLC24 @IASLC
Tweet media one
1
4
74
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
3 years
You know your patients KNOW you, when they bring you homemade snacks to get through the day! I am always humbled by my patient’s generosity #LCSM @PennMedicine @PennMDForum @PennCancer
Tweet media one
4
1
73
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
1 year
#ASCO23 @ASCO #CHRYSALIS ✨N=108, Med f/u 10.2 mo ✨101 evaluate ✨ORR 30%, mDOR 10.8 months ✨ mPFS 5.7 months ✨ ORR 61% vs 14% in MET IHC+/- @EGFRResisters @OncoAlert @BenjaminBesseMD @Jbauml
Tweet media one
Tweet media two
Tweet media three
Tweet media four
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
1 year
#ASCO23 @ASCO 👇🏽Today at Opening #LCSM CSS #CHRYSALIS Important Question: METIHC or FISH in Progression on Osimertinib in #EGFRMT #NSCLC @BenjaminBesseMD @Jbauml @OncoAlert @HemOncToday @LungCancerRx
1
5
7
4
27
72
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
2 years
Kicking off #WCLC22 with @IASLC president ⁦ @HwakeleeMD Karen Kelly⁩ in #Vienna ⁦ #LCSM ⁦ @LeciaSequist ⁩ ⁦ @KHigginsMD ⁩ ⁦ @triparnasen ⁩ ⁦ @ChristianRolfo ⁩ ⁦ @danieltanmd ⁩
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
5
72
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
4 years
I LOVE daylight saving time Sunday morning. Said NO one.
5
3
71
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
4 years
Plasma based NGS testing is now considered standard of care for testing of molecular mutations in #NSCLC . Terrific start to the day #LiquidBiopsy20 @drgandara discusses approvals of current assays including @GuardantHealth and @FoundationOne #LCSM @IASLC
Tweet media one
Tweet media two
2
25
70
@CharuAggarwalMD
Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
1 year
#ASCO23 @ASCO Congratulations to @HwakeleeMD @DoctorJSpicer on this @NEJM pub!! @OncoAlert
Tweet media one
0
15
72